Medi Caps
add_icon

Medi Caps

28.52
-1.00
(-3.39%)
Market Cap
35.55 Cr
PE Ratio
-8.43
Volume
5,199.00
Day High - Low
31.78 - 28.52
52W High-Low
46.99 - 21.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
35.55 Cr
EPS
-0.46
PE Ratio
-8.43
PB Ratio
0.32
Book Value
93.51
EBITDA
0.90
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
-0.47
Debt to Equity
0.00
Forecast For
Actual

Company News

View All News
Caret
neutral
Medi-Caps Limited confirms it doesn't qualify as Large Corporate under SEBI debt securities framework, with zero outstanding borrowings as on March 31, 2026, making compliance requirements non-applicable.
neutral
Medi-Caps Limited informs shareholders about SEBI's special window for transfer and dematerialisation of physical securities sold/purchased before April 1, 2019, available from February 5, 2026 to February 4, 2027.
neutral
Medi-Caps Limited reported Q3FY26 results with standalone profit of ₹28.50 lacs but consolidated loss of ₹76.58 lacs. Real estate division showed improvement while pharma segment faced challenges.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,680.10
#1 4,03,112.27
36.57
#1 54,729.00
9.71
#1 10,980
16.07
42.76
6,378.50
1,69,329.13
67.34
9,712.00
18.67
2,191
-1.02
64.61
4,147.20
1,40,360.09
60.79
11,539.40
6.99
1,911
26.24
48.05
1,331.00
1,11,090.99
#1 18.39
33,741.20
16.73
5,725
-15.28
65.07
2,341.40
1,07,012.10
22.59
22,909.50
13.74
3,306
#1 37.44
57.36
1,305.90
1,05,488.08
22.01
28,409.50
7.12
5,291
-57.18
64.00
946.35
95,224.95
18.61
23,511.00
18.55
4,615
-0.32
63.05
2,292.90
94,652.07
51.17
12,744.20
#1 20.90
2,007
7.65
72.17
1,435.40
83,368.26
23.68
32,345.60
9.43
3,484
7.59
73.85
5,520.50
66,005.86
27.67
13,458.30
3.70
2,216
1.90
52.98
Growth Rate
Revenue Growth
1.44 %
Net Income Growth
-72.73 %
Cash Flow Change
-26.95 %
ROE
-74.59 %
ROCE
-34.31 %
EBITDA Margin (Avg.)
102.53 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
9
16
12
16
16
12
10
7
12
15
18
14
17
17
18
18
13
16
11
10
6
6
7
8
6
9
4
9
3
4
5
Expenses
10
13
11
13
15
14
12
9
10
11
15
11
14
14
16
17
12
14
9
10
7
6
6
8
7
8
6
7
6
5
5
EBITDA
-1
3
1
2
1
-2
-3
-2
2
3
4
3
4
4
2
1
1
3
2
1
-1
1
1
-1
-0
1
-2
2
-3
-1
-0
Operating Profit %
-26 %
18 %
14 %
13 %
5 %
-4 %
-45 %
-52 %
17 %
23 %
20 %
16 %
21 %
20 %
11 %
-3 %
5 %
11 %
14 %
4 %
-14 %
8 %
8 %
-13 %
-5 %
5 %
-45 %
-4 %
-126 %
-145 %
-25 %
Depreciation
0
0
0
1
1
0
1
0
0
0
0
0
1
1
1
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
-2
3
2
2
1
-2
-3
-1
2
3
3
3
3
3
2
2
1
2
1
1
-1
0
0
-1
-1
0
-2
2
-4
-2
-1
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
1
1
0
0
0
-0
0
0
0
Net Profit
-2
3
2
2
1
-2
-3
-1
2
3
3
3
3
3
2
2
1
2
-1
0
-1
0
-0
-1
-1
0
-2
2
-4
-2
-1
EPS in ₹
-1.41
2.16
1.77
1.80
1.60
-1.54
-2.63
-0.90
2.33
2.89
3.45
2.42
3.20
2.56
1.64
1.20
0.48
1.72
-1.07
-0.31
-0.89
0.09
-0.13
-0.86
-0.45
0.25
-1.64
1.38
-2.80
-1.46
-0.61

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
89
93
97
101
107
95
115
130
126
127
125
Fixed Assets
58
56
62
61
60
57
58
59
59
59
57
Current Assets
27
32
33
37
42
33
53
67
60
60
53
Capital Work in Progress
0
0
0
0
0
1
1
0
0
0
0
Investments
2
3
8
11
16
22
29
31
32
38
43
Other Assets
30
34
27
29
31
15
27
40
35
30
25
Total Equity & Liabilities
89
93
97
101
107
95
115
130
126
127
125
Current Liabilities
6
10
7
9
9
3
9
13
6
5
3
Non Current Liabilities
2
1
2
2
2
1
1
1
1
1
1
Total Equity
81
82
89
90
96
91
105
116
119
121
121
Reserve & Surplus
69
70
77
78
83
79
92
104
106
109
109
Share Capital
13
13
13
13
13
13
13
13
13
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
1
0
0
-1
6
3
-9
-1
0
Investing Activities
-7
-2
3
-4
-6
-6
-10
-4
-3
-8
-5
Operating Activities
7
3
4
4
6
5
15
7
-6
7
5
Financing Activities
0
-1
-6
0
-0
-0
-0
0
0
0
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
50.14 %
50.14 %
50.13 %
50.13 %
50.13 %
50.13 %
50.13 %
50.13 %
50.13 %
50.13 %
50.13 %
50.13 %
50.13 %
50.13 %
50.43 %
50.62 %
50.77 %
50.77 %
50.77 %
50.76 %
51.36 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.02 %
0.02 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
47.78 %
47.23 %
47.68 %
47.63 %
47.66 %
45.22 %
45.17 %
44.91 %
45.14 %
44.74 %
44.41 %
44.59 %
44.83 %
44.60 %
44.07 %
44.37 %
44.57 %
44.34 %
44.31 %
44.43 %
43.93 %
Others
2.05 %
2.60 %
2.15 %
2.21 %
2.18 %
4.62 %
4.67 %
4.93 %
4.70 %
5.10 %
5.43 %
5.24 %
5.01 %
5.24 %
5.48 %
4.99 %
4.63 %
4.86 %
4.89 %
4.79 %
4.68 %
No of Share Holders
0
4,068
4,301
4,623
4,908
18,197
17,752
16,993
15,308
14,566
13,790
13,226
12,356
11,738
11,255
11,176
11,033
10,851
10,692
10,493
10,349

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
26 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2024 48.52 50.50
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 54.19 50.81
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 49.22 46.56
21 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 May 2025 43.51 43.89
05 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Aug 2025 42.16 43.17
18 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Sept 2025 43.17 38.83
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 37.45 37.52
11 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2026 25.98 24.96

Announcements

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 08, 2026
Information For Shareholders Regarding Opening Of Special Window For Transfer And Dematerialization Of Physical Securities.Apr 04, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2026
Closure of Trading WindowMar 25, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2026
Unaudited Standalone & Consolidated Financial Results For The Quarter & Nine Month Ended 31.12.2025Feb 11, 2026
Board Meeting Outcome for Outcome Of Board Meeting Dated 11.02.2026Feb 11, 2026
Board Meeting Intimation for (Serial No. 04/2025-26) Of The Company Scheduled To Be Held On Wednesday 11Th Day Of February 2026 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 04, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Closure of Trading WindowDec 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter As Well As Half Year Ended On 30Th September 2025 Along With Statement Of Assets And Liabilities Cash Flow Statement And Limited Review Report.Nov 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 12.11.2025.Nov 12, 2025
Board Meeting Intimation for (Serial No. 03/2025-26) Of The Company Scheduled To Be Held On Wednesday 12Th Day Of November 2025 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Nov 04, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Closure of Trading WindowSep 26, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 19, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 19, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 28, 2025
Information Regarding E-Voting For 42Nd Annual General MeetingAug 26, 2025
Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository ParticipantsAug 26, 2025
Reg. 34 (1) Annual Report.Aug 26, 2025
Submission Of Notice Of Convening 42Nd AGM Of The Company.Aug 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Submission Of Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 30.06.2025Aug 05, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 05, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 05, 2025
Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON TUESDAY 05TH AUGUST 2025 PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015.Aug 05, 2025
Board Meeting Intimation for Board Meeting (Serial No. 02/2025-26) Of The Company Scheduled To Be Held On Tuesday 05Th Day Of August 2025 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jul 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 04, 2025
Closure of Trading WindowJun 26, 2025
Intimation Of Receipts Of Work Completion CertificateJun 16, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Intimation To The Holders Of Physical Shares In Terms Of SEBI Circular No. SEBI/HO/MIRSD/MIRSD-Pod-1/P/CIR/2023/37 Dated March 16 2023 Regarding Mandatory Furnishing Of PAN KYC Details And Nomination.May 27, 2025
Announcement Under Regulation 30 (LODR) Update In U. S. FDA Inspection Of Wholly Owned SubsidiaryMay 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 21, 2025
Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended 31.03.2025May 21, 2025
Board Meeting Outcome for HELD ON WEDNESDAY 21ST MAY 2025 PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015. May 21, 2025
Board Meeting Intimation for Intimation For Meeting Of Board Of Directors (Serial No. 01/2025-26) Of The Company Scheduled To Be Held On Wednesday 21St Day Of May 2025 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) RegMay 14, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Closure of Trading WindowMar 26, 2025
Intimation Under Regulation 30 For Inspection Of U.S. FDA Of Wholly Owned SubsidiaryFeb 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2025
Integrated Filing (Financial)Feb 12, 2025
Unaudited Standalone And Consolidated Results For The Quarter 31.12.204Feb 12, 2025
Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 12TH FEBRUARY 2025 PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015Feb 12, 2025

Technical Indicators

RSI(14)
Neutral
60.73
ATR(14)
Volatile
2.56
STOCH(9,6)
Neutral
77.46
STOCH RSI(14)
Neutral
79.32
MACD(12,26)
Bullish
0.46
ADX(14)
Strong Trend
42.03
UO(9)
Bearish
57.63
ROC(12)
Uptrend And Accelerating
22.49
WillR(14)
Neutral
-26.32